RBC Capital Maintains Outperform on Chemed, Raises Price Target to $587
RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:CHE) with a Outperform and raises the price target from $545 to $587.
Earnings Scheduled For February 23, 2023
Companies Reporting Before The Bell
• ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Chemed Q3 EPS $4.74 Beats $4.65 Estimate
Chemed (NYSE:CHE) reported quarterly earnings of $4.74 per share which beat the analyst consensus estimate of $4.65 by 1.94 percent. This is a 6.32 percent decrease over earnings of $5.06 per share from the same period
RBC Capital Maintains Outperform on Chemed, Lowers Price Target to $541
RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:CHE) with a Outperform and lowers the price target from $592 to $541.
Recap: Chemed Q2 Earnings
Chemed (NYSE:CHE) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:15 PM.
Here's what investors need to know about the announcement.
Earnings
Chemed beat estimated earnings by 1.26%, reporting an EPS of $4.84 versus an estimate of $4.78.
Earnings Scheduled For July 27, 2022
Companies Reporting Before The Bell
• Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.
Earnings Scheduled For October 28, 2021
Companies Reporting Before The Bell
• LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million.